Garry Nolan

Dr. Nolan received his Ph.D from the Department of Genetics at Stanford at the Herzenberg laboratory, and his B.S. in Genetics from Cornell University, and was a postdoctoral fellow in the laboratory of Dr. David Baltimore at MIT and Rockefeller University. He is the author of over 120 peer-reviewed papers and holds numerous issued patents. He is the recipient of several prestigious awards, and was recently honored as one of the top 25 inventors at Stanford University. He was a Hume Faculty Scholar (1993–98), Trustee of the Leukemia Society of America (1995–98), Burroughs Welcome Fund New Investigator Awardee (1996–2000), HHMI Junior Faculty Scholar Awardee, Leukemia and Lymphoma Society Stohlman Scholar (2000), among others. He is the co-founder of 3 companies, including publicly traded RIGEL (NASDAQ:RIGL).